In the News

Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19

A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.

Flu-like illnesses appeared to spread through primary care office visits

A new study's findings on the spread of influenza offered lessons on reopenings of outpatient clinics during the pandemic and the value of virtual visits for patients with suspected respiratory infections, the authors said.

MKSAP Quiz: Follow-up evaluation for nephrolithiasis

A 61-year-old woman has a follow-up evaluation for the incidental discovery of several hypodense lesions in both lobes of her liver and a 2.5-cm mesenteric mass during CT imaging for nephrolithiasis. She has fully recovered from the nephrolithiasis and now feels entirely well. Following a physical exam and lab studies, what is the most appropriate management?

MKSAP 19, with new features, set for release Aug. 31

An interactive virtual party, “MKSAP 19 Countdown to Launch,” will be held on Thursday, Aug. 12, from 1 to 2 p.m. ET on Facebook.

Guideline provides clinical recommendations for treating hypersomnolence disorders

The American Academy of Sleep Medicine guideline provides recommendations for clinicians choosing prescription drugs to treat disorders such as narcolepsy, idiopathic hypersomnia, and hypersomnolence secondary to other conditions.

New College resources help physicians with best practices for E/M documentation

New resources from ACP and the Electronic Health Record Association include guidance for general internal medicine specialists and subspecialists.

Put words in our mouth

ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.